BioSpace News Archive

Bittium Exhibits Its Innovative High-Tech Products and Solutions for Cardiology and Neurology at Medica 2019

Bittium exhibits its innovative products and solutions for cardiology and neurology at Medica 2019, the leading international trade fair for the medical sector, on November 18-21 in Dusseldorf, Germany.

November 19, 2019
·
4 min read
Policy

Levo Therapeutics Receives Fast Track Designation From FDA for Intranasal Carbetocin for the Treatment of Prader-Willi Syndrome

Levo Therapeutics, Inc. announced that the U.S. Food and Drug Administration has granted Fast Track designation for LV-101 for the treatment of Prader-Willi syndrome Levo is currently enrolling participants in its Phase 3 clinical study of intranasal carbetocin for the treatment of PWS.

November 19, 2019
·
4 min read
Business

Regenstrief Institute names inaugural VP for data and analytics

Shaun Grannis, M.D., M.S., an internationally recognized expert in informatics, data analytics, and biosurveillance, has been named the Regenstrief Institute’s first vice president of data and analytics.

November 19, 2019
·
5 min read
Business

Epigenomics AG Reports Financial Results for the First Nine Months 2019

Epigenomics AG announced its financial results for the first nine months of 2019.

November 19, 2019
·
4 min read
Deals

£1.2m investment to reinforce Stevenage Campus as world class cell and gene therapy hub

Hertfordshire Local Enterprise Partnership is to invest £1.2m into Stevenage Bioscience Catalyst (SBC) to help grow a world-class cell and gene therapy cluster.

November 19, 2019
·
4 min read
Business

Optibrium collaborates with Enamine and BioSolveIT to add REAL Space Search Tool to StarDrop

New extension enables researchers to explore the REAL Space of 11 billion readily accessible compounds directly from StarDrop

November 19, 2019
·
5 min read
Policy

OGT continues move into molecular diagnostics markets with MDSAP certification

Oxford Gene Technology, A Sysmex Group Company, is proud to announce that its new facility in Cambridge, UK, has achieved Medical Device Single Audit Program certification of its quality management system

November 19, 2019
·
3 min read
WuXi Biologics Congratulates Tychan on the World’s First Yellow Fever Antibody Tested Safe and Efficacious in Human Volunteers

WuXi Biologics congratulates its partner Tychan on successful completion of the Phase 1A/1B safety and efficacy trials in Singapore for TY014, a first-in-class monoclonal antibody candidate treatment for Yellow Fever

November 19, 2019
·
4 min read
Zelluna Immunotherapy and Glycostem Therapeutics announce partnership to develop allogeneic TCR-NK therapies

Zelluna Immunotherapy, a biopharma company developing T-cell receptor guided adoptive cell therapy products for the treatment of multiple solid cancers, and Glycostem Therapeutics BV, announce that they have entered into a development, license and supply agreement.

November 19, 2019
·
4 min read
BioCity UK Life Science Start-Up Report reveals a ‘baby boom’ of new life science ventures driven by unprecedented levels of investment; and predict a proliferation of life science workspace

BioCity, the pioneering life science incubator and business collective today releases its biennial publication, the UK Life Science Start-Up Report, an in-depth analysis of emerging businesses within the life sciences across the UK.

November 19, 2019
·
4 min read